Council on Radionuclides & Radiopharm
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Council on Radionuclides & Radiopharm
Names of Lobbyists
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Energy & Nuclear Power
Most Frequently Disclosed Bills
Bill No. Title S.99 American Medical Isotopes Production Act of 2011 H.R.1483 Drug Safety Enhancement Act of 2011 H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.3630 Middle Class Tax Relief and Job Creation Act of 2011 H.R.3026 Safeguarding America's Pharmaceuticals Act of 2011 H.R.4095 Online Pharmacy Safety Act H.R.5651 Food and Drug Administration Reform Act of 2012 S.3187 Food and Drug Administration Safety and Innovation Act